International Health Sciences Review

OCT 21, 2026 · JOURNAL ARTICLE

Bariatric surgery compared with GLP-1 receptor agonists: durability of weight loss and control of comorbidities

International Health Sciences Review

The expanding efficacy of incretin-based pharmacotherapy has changed the comparison between metabolic and bariatric surgery and medical obesity treatment. This narrative critical r

OCT 6, 2026 · JOURNAL ARTICLE

High-risk pulmonary embolism: Risk stratification and criteria for thrombolysis

International Health Sciences Review

High-risk pulmonary embolism is a time-critical form of venous thromboembolism in which acute right ventricular failure can progress rapidly from compensated obstruction to shock a

SEP 19, 2026 · JOURNAL ARTICLE

Localized prostate cancer: Active surveillance compared with radical treatment and quality of life

International Health Sciences Review

Localized prostate cancer is characterized by marked biological heterogeneity, creating a therapeutic dilemma in which the reduction of progression and metastatic risk must be weig

SEP 19, 2026 · JOURNAL ARTICLE

High-Risk Dyslipidemia: Lipid targets, high-intensity statins, and novel lipid-lowering agents

International Health Sciences Review

High-risk dyslipidemia is a treatment problem defined less by an isolated cholesterol value than by the interaction between atherogenic lipoprotein burden and absolute cardiovascul

SEP 16, 2026 · JOURNAL ARTICLE

Hypertrophic Cardiomyopathy: Family screening, sudden cardiac death risk stratification, and management

International Health Sciences Review

Hypertrophic cardiomyopathy (HCM) is characterized by marked clinical and genetic heterogeneity, which makes early identification of affected relatives and prevention of sudden car

AUG 11, 2026 · JOURNAL ARTICLE

From therapeutic benefit to cardiovascular risk: a multidisciplinary review on anabolic steroids

International Health Sciences Review

A narrative review synthesizing evidence on therapeutic versus abusive AAS use and cardiovascular risk, offering multidisciplinary clinical management recommendations rather than reporting a primary study result.